Go to JCI Insight
  • About
  • Editors
  • Consulting Editors
  • For authors
  • Publication ethics
  • Publication alerts by email
  • Advertising
  • Job board
  • Contact
  • Clinical Research and Public Health
  • Current issue
  • Past issues
  • By specialty
    • COVID-19
    • Cardiology
    • Gastroenterology
    • Immunology
    • Metabolism
    • Nephrology
    • Neuroscience
    • Oncology
    • Pulmonology
    • Vascular biology
    • All ...
  • Videos
    • Conversations with Giants in Medicine
    • Video Abstracts
  • Reviews
    • View all reviews ...
    • Complement Biology and Therapeutics (May 2025)
    • Evolving insights into MASLD and MASH pathogenesis and treatment (Apr 2025)
    • Microbiome in Health and Disease (Feb 2025)
    • Substance Use Disorders (Oct 2024)
    • Clonal Hematopoiesis (Oct 2024)
    • Sex Differences in Medicine (Sep 2024)
    • Vascular Malformations (Apr 2024)
    • View all review series ...
  • Viewpoint
  • Collections
    • In-Press Preview
    • Clinical Research and Public Health
    • Research Letters
    • Letters to the Editor
    • Editorials
    • Commentaries
    • Editor's notes
    • Reviews
    • Viewpoints
    • 100th anniversary
    • Top read articles

  • Current issue
  • Past issues
  • Specialties
  • Reviews
  • Review series
  • Conversations with Giants in Medicine
  • Video Abstracts
  • In-Press Preview
  • Clinical Research and Public Health
  • Research Letters
  • Letters to the Editor
  • Editorials
  • Commentaries
  • Editor's notes
  • Reviews
  • Viewpoints
  • 100th anniversary
  • Top read articles
  • About
  • Editors
  • Consulting Editors
  • For authors
  • Publication ethics
  • Publication alerts by email
  • Advertising
  • Job board
  • Contact

Citations to this article

Pulmonary abnormalities in intermediate alpha-1-antitrypsin deficiency.
W J Hall, … , Y P Chaubey, P L Townes
W J Hall, … , Y P Chaubey, P L Townes
Published November 1, 1976
Citation Information: J Clin Invest. 1976;58(5):1069-1077. https://doi.org/10.1172/JCI108558.
View: Text | PDF
Research Article Article has an altmetric score of 3

Pulmonary abnormalities in intermediate alpha-1-antitrypsin deficiency.

  • Text
  • PDF
Abstract

Pulmonary function studies were carried out in a group of asymptomatic nonsmoking adults with intermediate alpha-1-antitrypsin deficiency who were attending an early disease detection unit in Rochester, N. Y. All subjects were identified by specific protease inhibitor (Pi) typing. Fifteen MZ and 14 MS subjects who had never smoked cigarettes were matched by sex and age to MM controls. Spirometry, static lung volumes, and single breath-diffusing capacity were identical in all Pi type groups with no statistically significant differences noted. Maximal expiratory flow volume curves were obtained in all subjects. MZ subjects demonstrated statistically impaired maximal flow rates at 75%, 50%, and 25% of vital capacity compared to their MM controls. Total pulmonary resistance by the oscillometric method was measured at 3, 5, 7, and 9 cycle/s in the same subjects. Increased frequency dependence of resistance (defined as the difference between total pulmonary resistance at 3 cycle/s and 9 cycle/s) was observed in MZ subjects compared to MM controls. No differences were noted by this method in MS-MM pairs. The data suggest that detectable mechanical abnormalities are present in subjects with the MZ phenotype, even in the absence of established risk factors such as cigarette smoking and high air pollution.

Authors

W J Hall, R W Hyde, R H Schwartz, G S Mudholkar, D R Webb, Y P Chaubey, P L Townes

×

Total citations by year

Year: 2017 2016 2004 2002 2000 1999 1988 1987 1983 1981 1980 1979 Total
Citations: 2 1 1 1 1 1 1 1 1 1 1 2 14
Citation information
This citation data is accumulated from CrossRef, which receives citation information from participating publishers, including this journal. Not all publishers participate in CrossRef, so this information is not comprehensive. Additionally, data may not reflect the most current citations to this article, and the data may differ from citation information available from other sources (for example, Google Scholar, Web of Science, and Scopus).

Citations to this article (14)

Title and authors Publication Year
COPD in individuals with the PiMZ alpha-1 antitrypsin genotype
HS Ashry, C Strange
European Respiratory Review 2017
Maximal mid-expiratory flow detects early lung disease in α 1 -antitrypsin deficiency
JA Stockley, AM Ismail, SM Hughes, R Edgar, RA Stockley, E Sapey
The European respiratory journal : official journal of the European Society for Clinical Respiratory Physiology 2017
Historical role of alpha-1-antitrypsin deficiency in respiratory and hepatic complications
L Zuo, BK Pannell, T Zhou, CC Chuang
Gene 2016
Chronic obstructive pulmonary disease in alpha1-antitrypsin PI MZ heterozygotes: a meta-analysis
CP Hersh, M Dahl, NP Ly, CS Berkey, BG Nordestgaard, EK Silverman
Thorax 2004
Influence of deficient α1-anti-trypsin phenotypes on clinical characteristics and severity of asthma in adults
M Miravitlles, S Vilà, M Torrella, E Balcells, F Rodríguez-Frías, CL Roza, R Jardí, R Vidal
Respiratory Medicine 2002
Genetic Risk Factors for Chronic Obstructive Pulmonary Disease
AJ Sandford, PD Paré
Clinics in Chest Medicine 2000
Z and S Mutations of the α 1 -Antitrypsin Gene and the Risk of Chronic Obstructive Pulmonary Disease
AJ Sandford, TD Weir, JJ Spinelli, PD Paré
American journal of respiratory cell and molecular biology 1999
Natural history of alpha-1-protease inhibitor deficiency
DC Hutchison
The American Journal of Medicine 1988
Southwestern Internal Medicine Conference: Pulmonary Emphysema: Current Concepts of Pathogenesis
JC Weissler
The American Journal of the Medical Sciences 1987
Lung function in an Australian population: contributions of polygenic factors and the Pi locus to individual differences in lung function in a sample of twins
JB Gibson, NG Martin, JG Oakeshott, DM Rowell, P Clark
Annals of Human Biology 1983
Replacement therapy of alpha 1-antitrypsin deficiency. Reversal of protease-antiprotease imbalance within the alveolar structures of PiZ subjects
JE Gadek, HG Klein, PV Holland, RG Crystal
Journal of Clinical Investigation 1981
Danazol-induced Augmentation of Serum α1-Antitrypsin Levels in Individuals with Marked Deficiency of this Antiprotease
JE Gadek, JD Fulmer, JA Gelfand, MM Frank, TL Petty, RG Crystal
Journal of Clinical Investigation 1980
Assessment of alpha-1-antitrypsin deficiency heterozygosity as a risk factor in the etiology of emphysema. Physiological comparison of adult normal and heterozygous protease inhibitor phenotype subjects from a random population
DJ McDonagh, SP Nathan, RJ Knudson, MD Lebowitz
Journal of Clinical Investigation 1979
Lung distensibility and airway function in intermediate alpha 1-antitrypsin deficiency (Pi MZ)
SF Tattersall, RP Pereira, D Hunter, G Blundell, NB Pride
Thorax 1979

Advertisement

Copyright © 2025 American Society for Clinical Investigation
ISSN: 0021-9738 (print), 1558-8238 (online)

Sign up for email alerts

Referenced in 1 clinical guideline sources
7 readers on Mendeley
See more details